Uscom Limited (UCM.AX)
- Previous Close
0.0310 - Open
0.0310 - Bid 0.0300 x 17274400
- Ask 0.0400 x 17570600
- Day's Range
0.0310 - 0.0310 - 52 Week Range
0.0230 - 0.0540 - Volume
16,000 - Avg. Volume
24,546 - Market Cap (intraday)
7.582M - Beta (5Y Monthly) -0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 8, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company also provides the SpiroSonic AIR, a technology based on digital transit-time ultrasound comprising enhanced wireless and internet connectivity that allows clinicians to interface with several proprietary apps and software platforms; eHealth, which profiles cardiovascular and pulmonary function in a novel way; and respiratory devices. It serves hospitals and other medical care locations through a network of distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.
www.uscom.com.auRelated News
Performance Overview: UCM.AX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UCM.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UCM.AX
Valuation Measures
Market Cap
7.58M
Enterprise Value
7.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.52
Price/Book (mrq)
3.53
Enterprise Value/Revenue
2.22
Enterprise Value/EBITDA
-4.78
Financial Highlights
Profitability and Income Statement
Profit Margin
-62.47%
Return on Assets (ttm)
-19.78%
Return on Equity (ttm)
-61.60%
Revenue (ttm)
3.36M
Net Income Avi to Common (ttm)
-2.1M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
3.18M
Total Debt/Equity (mrq)
141.72%
Levered Free Cash Flow (ttm)
-654.25k
Company Insights: UCM.AX
UCM.AX does not have Company Insights